Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ) SHZ

56.60

+0.19(+0.34%)

Updated at October 20 09:25AM

Currency In CNY

Shenzhen Salubris Pharmaceuticals Co., Ltd.

Address

NEO Greenview Plaza, Block B

Shenzhen, 518040

China

Phone

86 755 8386 7888

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Employees

3596

First IPO Date

September 10, 2009

Key Executives

NameTitlePayYear Born
Ms. Yun Kong CPAChief Financial Officer, Accounting Supervisor & Financial Manager01973
Dr. Xie Heng M.D., Ph.D.Chief Medical Officer0N/A
Ms. Song Ping ZhaoDeputy General Manager01970
Mr. Jianfeng YangSecretary of the Board of Directors & Non Independent Director01975
Mr. Jie YanGM & Director01972
Mr. Ping ChenDeputy General Manager01970

Description

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines for cardiovascular, anti-diabetic, antineoplastic, and orthopedic therapeutic in China. It offers cardiovascular and cerebrovascular products, such as allisartan isoproxil, benazepril hydrochloride, desloratadine, and clopidogrel bisulfate tablets, as well as bivalirudin and pamidronate disodium injections; recombinant SeV-hFGF2/dF Injection for the treatment of diabetic foot disease; and anti-tumor and orthopedics medicines. The company also provides anti-infection products comprising cefonicid sodium, ceftazidime, ceftriaxone sodium, cefonicid sodium, cefminox sodium, cefuroxime sodium, cefepime hydrochloride, and cefodizime sodium injections, as well as azithromycin dispersible and levetiracetam tablets. In addition, it offers biotechnological drugs, such as recombinant protein and monoclonal antibody drugs. Further, the company is involved in import, licensing-in, and licensing-out medicines for Europe markets. The company was founded in 1998 and is headquartered in Shenzhen, China.